• Catoblepas
    link
    fedilink
    arrow-up
    27
    ·
    edit-2
    17 hours ago

    In phase 3 clinical trials by the drugmaker, researchers looked at how well the drug worked after surgery. Patients who had undergone either tummy tucks or bunion surgery were given either suzetrigine every 12 hours; an opioid, hydrocodone, plus Tylenol every six hours; or a placebo for 48 hours after the operations.

    [ . . . ]

    The dose of hydrocodone was also smaller than what is typically given after surgery, “so it’s hard to know exactly what to make of the results,” Rind said.

    🚩🚩🚩

    I’m not saying this is 100% what it is, but if I wanted to make a less effective drug look more effective, then comparing its performance to a smaller than normal dose of an approved drug would be one way to do it.

    If it’s actually effective then that’s great, there are people that need non-opiate alternatives. My worry is that it’s not and this is going to wind up being another way patients in acute pain get told to suck it up and deal by their doctors.

    • lennivelkant@discuss.tchncs.de
      link
      fedilink
      arrow-up
      1
      ·
      3 hours ago

      so it’s hard to know exactly what to make of the results

      Sounds like someone desperately trying to not ruin future grant chances by saying “this trial is absolutely worthless”…

    • janNatan@lemmy.ml
      link
      fedilink
      arrow-up
      11
      ·
      17 hours ago

      They seriously gave people a placebo for pain after surgery? That sounds horrible.

    • Fluke@discuss.online
      link
      fedilink
      arrow-up
      5
      ·
      17 hours ago

      The placebo control is key, and it was at least statistically better than placebo.

      You’re right that it’s hard to tell if it is more or less effective than hydrocodone+acetaminophen but it’s good news either way because it can potentially reduce the use of opioids and be another option.